These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 7612736)
1. Changes in biocompatibility of dialysis fluid during its dwell in the peritoneal cavity. Breborowicz A; Martis L; Oreopoulos DG Perit Dial Int; 1995; 15(2):152-7. PubMed ID: 7612736 [TBL] [Abstract][Full Text] [Related]
2. Effect of the dialysate effluent from CAPD patients on peritoneal mesothelial cells and fibroblasts. Breborowicz A; Patrikarea A; Martis L; Oreopoulos DG Adv Perit Dial; 1994; 10():230-4. PubMed ID: 7999835 [TBL] [Abstract][Full Text] [Related]
3. Role of peritoneal mesothelial cells and fibroblasts in the synthesis of hyaluronan during peritoneal dialysis. Breborowicz A; Wisniewska J; Polubinska A; Wieczorowska-Tobis K; Martis L; Oreopoulos DG Perit Dial Int; 1998; 18(4):382-6. PubMed ID: 10505559 [TBL] [Abstract][Full Text] [Related]
4. In vitro simulation of the effect of peritoneal dialysis solution on mesothelial cells. Breborowicz A; Rodela H; Karoń J; Martis L; Oreopoulos DG Am J Kidney Dis; 1997 Mar; 29(3):404-9. PubMed ID: 9041217 [TBL] [Abstract][Full Text] [Related]
5. Influence of neutral-pH dialysis solutions on the peritoneal membrane: a long-term investigation in rats. Wieczorowska-Tobis K; Polubinska A; Schaub TP; Schilling H; Wisniewska J; Witowski J; Passlick-Deetjen J; Breborowicz A Perit Dial Int; 2001; 21 Suppl 3():S108-13. PubMed ID: 11887803 [TBL] [Abstract][Full Text] [Related]
6. Peritoneal dialysis with solutions low in glucose degradation products is associated with improved biocompatibility profile towards peritoneal mesothelial cells. Witowski J; Korybalska K; Ksiazek K; Wisniewska-Elnur J; Jörres A; Lage C; Schaub TP; Passlick-Deetjen J; Breborowicz A; Grzegorzewska A; Ksiazek A; Liberek T; Lichodziejewska-Niemierko M; Majdan M; Rutkowski B; Stompór T; Sulowicz W Nephrol Dial Transplant; 2004 Apr; 19(4):917-24. PubMed ID: 15031350 [TBL] [Abstract][Full Text] [Related]
7. Sulodexide modulates the dialysate effect on the peritoneal mesothelium. Misian M; Baum E; Breborowicz A J Physiol Pharmacol; 2019 Dec; 70(6):. PubMed ID: 32203941 [TBL] [Abstract][Full Text] [Related]
8. In vitro study of the effect of osmotic solutes on the interactions between cells from the peritoneum and peritoneal cavity. Breborowicz A; Balaskas E; Oreopoulos GD; Martis L; Serkes K; Oreopoulos DG Perit Dial Int; 1994; 14(2):149-54. PubMed ID: 8043668 [TBL] [Abstract][Full Text] [Related]
9. Interactions of cells from peritoneal dialysate with mesothelial cells and fibroblasts in culture. Breborowicz A; Balaskas E; Oreopoulos GD; Vas M; Martis L; Serkes KD; Oreopoulos DG Adv Perit Dial; 1992; 8():7-10. PubMed ID: 1361856 [TBL] [Abstract][Full Text] [Related]
10. The in vitro biocompatibility performance of a 25 mmol/L bicarbonate/10 mmol/L lactate-buffered peritoneal dialysis fluid. Skoufos L; Topley N; Cooker L; Dawnay A; Millar DJ; Holmes CJ; Faict D Kidney Int Suppl; 2003 Dec; (88):S94-9. PubMed ID: 14870882 [TBL] [Abstract][Full Text] [Related]
12. Peritoneal transport during dialysis with amino acid-based solutions. Park MS; Heimbürger O; Bergström J; Waniewski J; Werynski A; Lindholm B Perit Dial Int; 1993; 13(4):280-8. PubMed ID: 8241328 [TBL] [Abstract][Full Text] [Related]
13. Changes in water transport across the peritoneum during treatment with continuous ambulatory peritoneal dialysis in selected patients with and without peritonitis. Radtke M; Albrektsen GE; Widerøe TE; Nilsen TI; Romundstad P; Hallan S; Aasarød K; Laegreid IK; Oien C Perit Dial Int; 2004; 24(6):571-9. PubMed ID: 15559487 [TBL] [Abstract][Full Text] [Related]
14. Peritoneal transport in peritoneal dialysis patients using glucose-based and amino acid-based solutions. Olszowska A; Waniewski J; Werynski A; Anderstam B; Lindholm B; Wankowicz Z Perit Dial Int; 2007; 27(5):544-53. PubMed ID: 17704445 [TBL] [Abstract][Full Text] [Related]
15. Intraperitoneal nitric oxide production in patients treated by continuous ambulatory peritonal dialysis. Davenport A; Fernando RL; Varghese Z Blood Purif; 2004; 22(2):216-23. PubMed ID: 15044821 [TBL] [Abstract][Full Text] [Related]
17. [Effect of dialysates on ultrastructure of mouse peritoneal mesothelium]. Li J; Zhong H; Zhang K; Chen Y; Xu P Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1999 Jun; 21(3):208-13. PubMed ID: 12569655 [TBL] [Abstract][Full Text] [Related]
18. Effect of bicarbonate/lactate peritoneal dialysis solutions on human mesothelial cell proliferation ex vivo. Bajo MA; del Peso G; Castro MA; Díaz C; Castro MJ; Gil F; Sánchez-Tomero JA; Selgas R Adv Perit Dial; 2001; 17():37-41. PubMed ID: 11510293 [TBL] [Abstract][Full Text] [Related]
19. Effect of hyaluronan-supplemented dialysate on in vitro function of human peritoneal mesothelial cells. Breborowicz A; Pyda M; Moberly J; Martis L; Oreopoulos D Am J Nephrol; 2004; 24(3):316-21. PubMed ID: 15148458 [TBL] [Abstract][Full Text] [Related]
20. The effect of N-acetylglucosamine as a substrate for in vitro synthesis of glycosaminoglycans by human peritoneal mesothelial cells and fibroblasts. Breborowicz A; Kuzlan-Pawlaczyk M; Wieczorowska-Tobis K; Wisniewska J; Tam P; French I; Wu G Adv Perit Dial; 1998; 14():31-5. PubMed ID: 10649686 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]